Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity
出版年份 2014 全文链接
标题
Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity
作者
关键词
antitumor effects, co-delivery, combination therapy, liposomes, omacetaxine mepesuccinate
出版物
PHARMACEUTICAL RESEARCH
Volume 31, Issue 8, Pages 2178-2185
出版商
Springer Nature
发表日期
2014-02-22
DOI
10.1007/s11095-014-1317-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells
- (2014) Guo-Sheng Wu et al. Pharmacological Reports
- Smart pH-Sensitive and Temporal-Controlled Polymeric Micelles for Effective Combination Therapy of Doxorubicin and Disulfiram
- (2013) Xiaopin Duan et al. ACS Nano
- Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
- (2013) J. Crown et al. ANNALS OF ONCOLOGY
- The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms
- (2013) Lenka Beranova et al. APOPTOSIS
- Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma
- (2013) Qingxing Xu et al. BIOMATERIALS
- Potentiation of in vitro and in vivoantitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
- (2013) Maggie J Rathos et al. BMC CANCER
- Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells
- (2013) H M Aliabadi et al. CANCER GENE THERAPY
- Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells
- (2013) Sun-Mi Yun et al. CANCER LETTERS
- Homoharringtonine/Omacetaxine Mepesuccinate: The Long and Winding Road to Food and Drug Administration Approval
- (2013) Hagop M. Kantarjian et al. Clinical Lymphoma Myeloma & Leukemia
- Nano-sized polymers and liposomes designed to deliver combination therapy for cancer
- (2013) Anat Eldar-Boock et al. CURRENT OPINION IN BIOTECHNOLOGY
- Omacetaxine mepesuccinate (synribo) – newly launched in chronic myeloid leukemia
- (2013) Aziz Nazha et al. EXPERT OPINION ON PHARMACOTHERAPY
- Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer
- (2013) Daniel Chan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA
- (2013) Oleh Taratula et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced Intrapulmonary Delivery of Anticancer siRNA for Lung Cancer Therapy Using Cationic Ethylphosphocholine-based Nanolipoplexes
- (2013) Gayong Shim et al. MOLECULAR THERAPY
- New and emerging combination therapies for esophageal cancer
- (2013) Marcus Wiedmann et al. Cancer Management and Research
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene
- (2012) Kihoon Nam et al. BIOMATERIALS
- Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma
- (2012) A. Younes et al. BLOOD
- Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors
- (2012) John Nemunaitis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells
- (2012) Hideko Akagi et al. Gastric Cancer
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508
- (2012) Yoshitoyo Kagami et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Advanced Materials for Co-Delivery of Drugs and Genes in Cancer Therapy
- (2012) Majad Khan et al. Advanced Healthcare Materials
- Small interfering RNA targeting mcl-1 enhances proteasome inhibitor-induced apoptosis in various solid malignant tumors
- (2011) Wei Zhou et al. BMC CANCER
- Molecular Chemotherapy and Chemotherapy: A New Front against Late-Stage Hormone-Refractory Prostate Cancer
- (2011) P. P. Singh et al. CLINICAL CANCER RESEARCH
- Omacetaxine as an Anticancer Therapeutic: What is Old is New Again
- (2011) Meir Wetzler et al. CURRENT PHARMACEUTICAL DESIGN
- Omacetaxine mepesuccinate for the treatment of leukemia
- (2011) Theo Daniel Kim et al. EXPERT OPINION ON PHARMACOTHERAPY
- Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells
- (2011) E K Allan et al. LEUKEMIA
- Enhanced tumor localization and retention of chlorin e6 in cationic nanolipoplexes potentiate the tumor ablation effects of photodynamic therapy
- (2011) Gayong Shim et al. NANOTECHNOLOGY
- Enhanced Transfection Rates of Small-Interfering RNA Using Dioleylglutamide-Based Magnetic Lipoplexes
- (2011) Soondong Lee et al. Nucleic Acid Therapeutics
- Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
- (2010) K. J. Campbell et al. BLOOD
- Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes
- (2010) Rae Sung Chang et al. Nanomedicine-Nanotechnology Biology and Medicine
- The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia
- (2009) K D Mason et al. LEUKEMIA
- Altering Chemosensitivity by Modulating Translation Elongation
- (2009) Francis Robert et al. PLoS One
- Combination chemotherapy with irinotecan and cisplatin in elderly patients (≥65 years) with extensive-disease small-cell lung cancer
- (2008) Hoon-Gu Kim et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More